- Home
- KPTI vs FKWL Comparison
KPTI vs FKWL Comparison
Compare KPTI & FKWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPTI
- FKWL
- Stock Information
- Founded
- KPTI 2008
- FKWL 1981
- Country
- KPTI United States
- FKWL United States
- Employees
- KPTI N/A
- FKWL N/A
- Industry
- KPTI Biotechnology: Pharmaceutical Preparations
- FKWL Telecommunications Equipment
- Sector
- KPTI Health Care
- FKWL Utilities
- Exchange
- KPTI Nasdaq
- FKWL Nasdaq
- Market Cap
- KPTI 66.7M
- FKWL 71.6M
- IPO Year
- KPTI 2013
- FKWL 1996
- Fundamental
- Price
- KPTI $7.53
- FKWL $6.28
- Analyst Decision
- KPTI Strong Buy
- FKWL
- Analyst Count
- KPTI 5
- FKWL 0
- Target Price
- KPTI $61.00
- FKWL N/A
- AVG Volume (30 Days)
- KPTI 144.0K
- FKWL 81.0K
- Earning Date
- KPTI 05-07-2025
- FKWL 02-14-2025
- Dividend Yield
- KPTI N/A
- FKWL N/A
- EPS Growth
- KPTI N/A
- FKWL N/A
- EPS
- KPTI N/A
- FKWL N/A
- Revenue
- KPTI $145,237,000.00
- FKWL $43,443,375.00
- Revenue This Year
- KPTI $4.37
- FKWL N/A
- Revenue Next Year
- KPTI $19.07
- FKWL N/A
- P/E Ratio
- KPTI N/A
- FKWL N/A
- Revenue Growth
- KPTI N/A
- FKWL N/A
- 52 Week Low
- KPTI $5.90
- FKWL $2.69
- 52 Week High
- KPTI $24.75
- FKWL $7.45
- Technical
- Relative Strength Index (RSI)
- KPTI 43.25
- FKWL 45.81
- Support Level
- KPTI $5.90
- FKWL $6.05
- Resistance Level
- KPTI $8.45
- FKWL $6.79
- Average True Range (ATR)
- KPTI 1.06
- FKWL 0.57
- MACD
- KPTI -0.01
- FKWL -0.12
- Stochastic Oscillator
- KPTI 36.38
- FKWL 23.86
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.
About FKWL Franklin Wireless Corp.
Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.